H

HaTay Pharmaceutical JSC
VN:DHT

Watchlist Manager
HaTay Pharmaceutical JSC
VN:DHT
Watchlist
Price: 94 900 VND -0.42% Market Closed
Market Cap: 7.8T VND
Have any thoughts about
HaTay Pharmaceutical JSC?
Write Note

Intrinsic Value

The intrinsic value of one DHT stock under the Base Case scenario is 18 609.17 VND. Compared to the current market price of 94 900 VND, HaTay Pharmaceutical JSC is Overvalued by 80%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DHT Intrinsic Value
18 609.17 VND
Overvaluation 80%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
HaTay Pharmaceutical JSC

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
DHT
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for DHT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about DHT?
Bearish
Neutral
Bullish

Fundamental Analysis

94 900 VND
-0.42%
-0.42%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

HaTay Pharmaceutical JSC
VN
Pharmaceuticals
Market Cap
7.8T VND
IPO
Dec 3, 2008
Employees
-
Vietnam
Market Cap
7.8T VND
Industry
Pharmaceuticals
IPO
Dec 3, 2008
Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about HaTay Pharmaceutical JSC

Provide an overview of the primary business activities
of HaTay Pharmaceutical JSC.

What unique competitive advantages
does HaTay Pharmaceutical JSC hold over its rivals?

What risks and challenges
does HaTay Pharmaceutical JSC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for HaTay Pharmaceutical JSC.

Provide P/S
for HaTay Pharmaceutical JSC.

Provide P/E
for HaTay Pharmaceutical JSC.

Provide P/OCF
for HaTay Pharmaceutical JSC.

Provide P/FCFE
for HaTay Pharmaceutical JSC.

Provide P/B
for HaTay Pharmaceutical JSC.

Provide EV/S
for HaTay Pharmaceutical JSC.

Provide EV/GP
for HaTay Pharmaceutical JSC.

Provide EV/EBITDA
for HaTay Pharmaceutical JSC.

Provide EV/EBIT
for HaTay Pharmaceutical JSC.

Provide EV/OCF
for HaTay Pharmaceutical JSC.

Provide EV/FCFF
for HaTay Pharmaceutical JSC.

Provide EV/IC
for HaTay Pharmaceutical JSC.

Compare the intrinsic valuations
of HaTay Pharmaceutical JSC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of HaTay Pharmaceutical JSC against its competitors.

Analyze the profit margins
(gross, operating, and net) of HaTay Pharmaceutical JSC compared to its peers.

Compare the P/E ratios
of HaTay Pharmaceutical JSC against its peers.

Discuss the investment returns and shareholder value creation
comparing HaTay Pharmaceutical JSC with its peers.

Analyze the financial leverage
of HaTay Pharmaceutical JSC compared to its main competitors.

Show all profitability ratios
for HaTay Pharmaceutical JSC.

Provide ROE
for HaTay Pharmaceutical JSC.

Provide ROA
for HaTay Pharmaceutical JSC.

Provide ROIC
for HaTay Pharmaceutical JSC.

Provide ROCE
for HaTay Pharmaceutical JSC.

Provide Gross Margin
for HaTay Pharmaceutical JSC.

Provide Operating Margin
for HaTay Pharmaceutical JSC.

Provide Net Margin
for HaTay Pharmaceutical JSC.

Provide FCF Margin
for HaTay Pharmaceutical JSC.

Show all solvency ratios
for HaTay Pharmaceutical JSC.

Provide D/E Ratio
for HaTay Pharmaceutical JSC.

Provide D/A Ratio
for HaTay Pharmaceutical JSC.

Provide Interest Coverage Ratio
for HaTay Pharmaceutical JSC.

Provide Altman Z-Score Ratio
for HaTay Pharmaceutical JSC.

Provide Quick Ratio
for HaTay Pharmaceutical JSC.

Provide Current Ratio
for HaTay Pharmaceutical JSC.

Provide Cash Ratio
for HaTay Pharmaceutical JSC.

What is the historical Revenue growth
over the last 5 years for HaTay Pharmaceutical JSC?

What is the historical Net Income growth
over the last 5 years for HaTay Pharmaceutical JSC?

What is the current Free Cash Flow
of HaTay Pharmaceutical JSC?

Discuss the annual earnings per share (EPS)
trend over the past five years for HaTay Pharmaceutical JSC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
HaTay Pharmaceutical JSC

Current Assets 810.2B
Cash & Short-Term Investments 219.3B
Receivables 143.5B
Other Current Assets 447.5B
Non-Current Assets 975B
Long-Term Investments 16.5B
PP&E 955.2B
Intangibles 1.4B
Other Non-Current Assets 1.9B
Current Liabilities 593.1B
Accounts Payable 147B
Accrued Liabilities 25.5B
Short-Term Debt 309.7B
Other Current Liabilities 110.8B
Non-Current Liabilities 141.6B
Long-Term Debt 110.8B
Other Non-Current Liabilities 30.8B
Efficiency

Earnings Waterfall
HaTay Pharmaceutical JSC

Revenue
2T VND
Cost of Revenue
-1.8T VND
Gross Profit
204.9B VND
Operating Expenses
-132.9B VND
Operating Income
72B VND
Other Expenses
-3.8B VND
Net Income
68.3B VND

Free Cash Flow Analysis
HaTay Pharmaceutical JSC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DHT Profitability Score
Profitability Due Diligence

HaTay Pharmaceutical JSC's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROE
Positive Gross Profit
Negative 1-Year Revenue Growth
Positive ROE
41/100
Profitability
Score

HaTay Pharmaceutical JSC's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

DHT Solvency Score
Solvency Due Diligence

HaTay Pharmaceutical JSC's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
56/100
Solvency
Score

HaTay Pharmaceutical JSC's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DHT Price Targets Summary
HaTay Pharmaceutical JSC

There are no price targets for DHT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DHT?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DHT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one DHT stock?

The intrinsic value of one DHT stock under the Base Case scenario is 18 609.17 VND.

Is DHT stock undervalued or overvalued?

Compared to the current market price of 94 900 VND, HaTay Pharmaceutical JSC is Overvalued by 80%.

Back to Top